Technical Intelligence & Insights
Dive into our comprehensive technical reports covering the Pharma Healthcare sector. We analyze novel patents, catalytic processes, and cost-reduction strategies to streamline your commercial manufacturing.
Novel patent CN114057655B enables high yield dibromopyrazine synthesis with mild conditions reducing cost and improving supply chain reliability for pharmaceutical intermediates.
Novel patent CN107759502B details a regulated-free route for Tiamulin. Enhances supply chain stability and reduces manufacturing costs for veterinary pharmaceutical intermediates.
Patent CN10449696966B details efficient Cu-catalyzed synthesis. Offers high yield and scalable production for global pharmaceutical supply chains.
Novel synthetic method for Abiraterone acetate ensures high purity and industrial scalability. Reliable supply chain partner for pharmaceutical intermediates.
Discover the patented protic solvent method for producing high-purity ketimines. A cost-effective, scalable solution for pharmaceutical intermediate manufacturing.
Novel patent CN105566319A details efficient moxifloxacin intermediate synthesis with high chiral purity and reduced costs for reliable supply chains.
Novel synthesis method for Syk inhibitor intermediate via selective nitration and hydrazine reduction, offering high yield and scalability for pharma supply chains.
Patent CN119504765A reveals a green Pd-catalyzed route for Alline alkaloids. Achieve high purity and cost reduction in pharmaceutical intermediates manufacturing with scalable technology.
Novel one-step synthesis improves yield by 15-30%. Offers cost-effective scalable production for global supply chains.
Patent CN117659009A reveals a chiral induction method for moxifloxacin side chain. This process offers significant cost reduction and supply chain reliability for pharmaceutical intermediates.
Patent CN105859648B reveals high-yield Peramivir intermediate synthesis. Offers significant cost reduction and supply chain reliability for pharmaceutical manufacturing partners globally.
Patent CN113929702A details a high-yield Everolimus synthesis using ethylene carbonate, offering significant cost reduction and safety advantages for pharmaceutical intermediate manufacturing.
Patent CN103467552A reveals a metal-free route for 8-cyclohexyl-2-fluoro-vidarabine. Enhanced purity and scalable manufacturing for anti-leukemia drug development.
Advanced synthesis of Barnidipine Hydrochloride via chiral resolution. High purity, scalable route for API manufacturing. Cost-effective solution for hypertension drugs.
Patent CN105418460B reveals safer Pimavanserin intermediate synthesis avoiding phosgene. Delivers cost reduction and supply chain reliability for pharmaceutical manufacturing.
Novel patent CN119894868B offers high-purity JAK inhibitor intermediate synthesis with reduced costs and scalable processes for reliable pharmaceutical intermediates supply chains.
Novel synthesis of Roxadustat via Bischler-Napieralski cyclization offers high purity and cost efficiency for pharmaceutical intermediate manufacturing.
Novel ruthenium-catalyzed route offers high-purity pharmaceutical intermediates with simplified supply chain and cost reduction capabilities.
Patent CN120484042B reveals a 5-step HE3286 synthesis route offering significant cost reduction in pharmaceutical manufacturing and high-purity API intermediate supply chain reliability.
Novel 9,11-epoxy route reduces steps and cost for fluorometholone manufacturing. Reliable supplier for high-purity steroid intermediates.